JENSEN FLEMMING STEEN
See Remarks
JENSEN FLEMMING STEEN has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 12, 2026.
On the most recent filing, JENSEN FLEMMING STEEN is listed as See Remarks at Ascendis Pharma A/S. Inside the rolling window, JENSEN FLEMMING STEEN reported no open-market purchases and 1 open-market sale totaling $4.6M in ASND.
Companies traded
Other insiders at ASND
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has JENSEN FLEMMING STEEN made?
JENSEN FLEMMING STEEN has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does JENSEN FLEMMING STEEN trade?
JENSEN FLEMMING STEEN has filed SEC Form 4 disclosures for 1 company, including ASND.
When was JENSEN FLEMMING STEEN's most recent SEC Form 4 filing?
JENSEN FLEMMING STEEN's most recent SEC Form 4 filing on Tracefour is dated May 12, 2026.
What is JENSEN FLEMMING STEEN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, JENSEN FLEMMING STEEN is listed as See Remarks.
What is JENSEN FLEMMING STEEN's total buy and sell value in the current window?
Inside the rolling retention window, JENSEN FLEMMING STEEN bought $0 and sold $4.6M based on SEC Form 4 filings.
What was JENSEN FLEMMING STEEN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 19,460 ASND shares on 2026-05-11, worth $4.6M, per SEC Form 4 filings.